RhumbLine Advisers’s Magellan Health Services, Inc. MGLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-69,291
| Closed | -$6.58M | – | 3040 |
|
|
2021
Q4 | $6.58M | Buy |
69,291
+1,194
| +2% | +$113K | 0.01% | 1211 |
|
|
2021
Q3 | $6.44M | Sell |
68,097
-10,416
| -13% | -$985K | 0.01% | 1197 |
|
|
2021
Q2 | $7.4M | Sell |
78,513
-506
| -0.6% | -$47.7K | 0.01% | 1195 |
|
|
2021
Q1 | $7.37M | Buy |
79,019
+3,055
| +4% | +$286K | 0.01% | 1184 |
|
|
2020
Q4 | $6.29M | Buy |
75,964
+6,278
| +9% | +$497K | 0.01% | 1225 |
|
|
2020
Q3 | $5.28M | Sell |
69,686
-4,359
| -6% | -$324K | 0.01% | 1139 |
|
|
2020
Q2 | $5.4M | Sell |
74,045
-3,385
| -4% | -$217K | 0.01% | 1164 |
|
|
2020
Q1 | $3.73M | Buy |
77,430
+2,723
| +4% | +$175K | 0.01% | 1209 |
|
|
2019
Q4 | $5.85M | Buy |
74,707
+4,773
| +7% | +$336K | 0.01% | 1159 |
|
|
2019
Q3 | $4.34M | Sell |
69,934
-2,115
| -3% | -$141K | 0.01% | 1264 |
|
|
2019
Q2 | $5.35M | Sell |
72,049
-2,245
| -3% | -$151K | 0.01% | 1157 |
|
|
2019
Q1 | $4.9M | Buy |
74,294
+663
| +0.9% | +$42.5K | 0.01% | 1192 |
|
|
2018
Q4 | $4.19M | Buy |
73,631
+11,295
| +18% | +$697K | 0.01% | 1213 |
|
|
2018
Q3 | $4.49M | Sell |
62,336
-17
| -0% | -$1.37K | 0.01% | 1179 |
|
|
2018
Q2 | $5.98M | Buy |
62,353
+2,596
| +4% | +$249K | 0.01% | 984 |
|
|
2018
Q1 | $6.4M | Buy |
59,757
+1,104
| +2% | +$111K | 0.01% | 892 |
|
|
2017
Q4 | $5.66M | Buy |
58,653
+8,160
| +16% | +$722K | 0.01% | 991 |
|
|
2017
Q3 | $4.36M | Buy |
50,493
+773
| +2% | +$60.9K | 0.01% | 1113 |
|
|
2017
Q2 | $3.63M | Sell |
49,720
-1,418
| -3% | -$99.6K | 0.01% | 1206 |
|
|
2017
Q1 | $3.53M | Buy |
51,138
+12,803
| +33% | +$935K | 0.01% | 1221 |
|
|
2016
Q4 | $2.88M | Sell |
38,335
-2,892
| -7% | -$185K | 0.01% | 1233 |
|
|
2016
Q3 | $2.21M | Buy |
41,227
+2,340
| +6% | +$141K | 0.01% | 1337 |
|
|
2016
Q2 | $2.56M | Sell |
38,887
-10,307
| -21% | -$694K | 0.01% | 1190 |
|
|
2016
Q1 | $3.34M | Buy |
49,194
+1,925
| +4% | +$116K | 0.01% | 1063 |
|
|
2015
Q4 | $2.92M | Buy |
47,269
+415
| +0.9% | +$22.3K | 0.01% | 1131 |
|
|
2015
Q3 | $2.6M | Sell |
46,854
-1,701
| -4% | -$103K | 0.01% | 1175 |
|
|
2015
Q2 | $3.4M | Sell |
48,555
-395
| -0.8% | -$26.9K | 0.01% | 1075 |
|
|
2015
Q1 | $3.47M | Sell |
48,950
-735
| -1% | -$46.3K | 0.01% | 1055 |
|
|
2014
Q4 | $2.98M | Buy |
49,685
+230
| +0.5% | +$13.6K | 0.01% | 1100 |
|
|
2014
Q3 | $2.71M | Buy |
49,455
+330
| +0.7% | +$18.9K | 0.01% | 1124 |
|
|
2014
Q2 | $3.06M | Buy |
49,125
+1,294
| +3% | +$76K | 0.01% | 1101 |
|
|
2014
Q1 | $2.84M | Sell |
47,831
-1,270
| -3% | -$75.6K | 0.01% | 1136 |
|
|
2013
Q4 | $2.94M | Sell |
49,101
-2,800
| -5% | -$167K | 0.01% | 1126 |
|
|
2013
Q3 | $3.11M | Sell |
51,901
-602
| -1% | -$34.9K | 0.01% | 1068 |
|
|
2013
Q2 | $2.94M | Buy |
+52,503
| New | +$2.75M | 0.01% | 1073 |
|
RhumbLine Advisers's MGLN Position: Q1 2022 in Review
RhumbLine Advisers sold out of Magellan Health Services, Inc. (MGLN) in Q1 2022, closing a stake of 69,291 shares — an estimated $6.58M sold.
RhumbLine Advisers first reported a position in MGLN in Q2 2013 and held it in 35 quarters. The position peaked at $7.4M in Q2 2021. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.
- RhumbLine Advisers reported no remaining Magellan Health Services, Inc. position as of Q1 2022 after selling out during the quarter.
- RhumbLine Advisers sold 69,291 Magellan Health Services, Inc. shares in Q1 2022, an estimated $6.58M.
- RhumbLine Advisers first reported a position in Magellan Health Services, Inc. in Q2 2013 and held it in 35 quarters.
- RhumbLine Advisers's Magellan Health Services, Inc. position peaked at $7.4M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2022.
Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.